This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Novamoxin (2017-11-07)
- Starting date:
- November 7, 2017
- Posting date:
- November 16, 2017
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- Healthcare Professionals, General Public, Hospitals
- Identification number:
- RA-65126
Affected products
Novamoxin
Reason
The homogeneity is out of specification in the affected lot.
Depth of distribution
Wholesalers and retailers (Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland,
Nova Scotia, Ontario, Quebec and Saskatchewan)
Affected products
Novamoxin
DIN, NPN, DIN-HIM
DIN 00452149
Dosage form
Granules For Suspension
Strength
125 MG / 5 ML
Lot or serial number
35437011A
Companies
- Recalling Firm
-
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA